Sartorius | SRT3 - Frais De Vente Et D'Administration





Frais De Vente Et D'Administration Changement Date
Akebia Therapeutics USD 23.53M 3.19M 2025-12
Alaunos Therapeutics USD 585K 84K 2025-09
Avita Medical AUD 19.03M 1.95M 2025-12
Dianthus Therapeutics USD 6.57M 1.62M 2025-12
Ionis Pharmaceuticals USD 151M 21M 2026-03
IQVIA Holdings USD 468M 46M 2025-12
Moderna USD 173M 135M 2026-03
Organon & Co USD 433M 34M 2025-12
Revvity USD 251.73M 9.82M 2025-12
Sartorius EUR 221.3M 500K 2026-03
Tectonic Therapeutic USD 3.44M 1.52M 2025-12
Viatris USD 1.03B 144.1M 2025-12
Xeris Pharmaceuticals USD 42.64M 3.82M 2025-12